Lupin Limited (NSE: LUPIN) secures U.S. FDA approval for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, marking a significant milestone.
Lupin Limited (LUPIN) announced U.S. FDA approval for Famotidine Injection, expanding its pharmaceutical portfolio with a bioequivalent to Pepcid®.